Free Trial

MetLife Investment Management LLC Has $5.20 Million Position in Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

MetLife Investment Management LLC lifted its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 8.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,331 shares of the business services provider's stock after acquiring an additional 4,461 shares during the period. MetLife Investment Management LLC owned approximately 0.11% of Exponent worth $5,197,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Barclays PLC raised its position in Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock valued at $11,127,000 after buying an additional 66,263 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Exponent by 223.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock valued at $541,000 after purchasing an additional 4,254 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Exponent by 63.6% in the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after purchasing an additional 245,086 shares in the last quarter. Argent Capital Management LLC boosted its holdings in Exponent by 17.3% during the fourth quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock worth $2,524,000 after purchasing an additional 4,173 shares during the last quarter. Finally, KBC Group NV grew its position in Exponent by 62.4% in the fourth quarter. KBC Group NV now owns 2,274 shares of the business services provider's stock valued at $203,000 after purchasing an additional 874 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.

Insider Activity at Exponent

In other Exponent news, VP Richard Reiss sold 1,736 shares of the stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.10% of the stock is owned by company insiders.

Exponent Price Performance

NASDAQ:EXPO traded down $0.89 on Monday, hitting $78.26. 118,293 shares of the company's stock were exchanged, compared to its average volume of 241,144. The firm has a 50-day moving average price of $81.36 and a 200-day moving average price of $90.74. Exponent, Inc. has a 52 week low of $73.83 and a 52 week high of $115.75. The company has a market cap of $3.97 billion, a P/E ratio of 36.94 and a beta of 0.84.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, beating the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter in the previous year, the firm earned $0.41 earnings per share. On average, research analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines